Stock COEP COEPTIS THERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Coeptis Therapeutics Holdings, Inc.

Equities

COEP

US19207A1088

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
0.285 USD +1.42% Intraday chart for Coeptis Therapeutics Holdings, Inc. +0.42% -63.64%
Jun. 17 Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy MT
Jun. 14 Coeptis Therapeutics Holdings, Inc. announced that it has received $4.3 million in funding CI

Evolution of the average Target Price on Coeptis Therapeutics Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6488a0b5385474b40ed60501b608ad._eGBWasP4s9kmd6BRe6sp8rvn9jumdMzt1n8TypNRj8.qoL5aeFmpaJWq_OsEIuc45ilybvZxrZVwzq4JGZ7F3eYpdYuyTi74hPthw~26364bb054ca85750ee6cc34012c537b

Analyst Recommendations on Coeptis Therapeutics Holdings, Inc.

Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy MT
Ladenburg Thalmann Starts Coeptis Therapeutics Holdings at Buy, $3 Price Target MT
EF Hutton Assumes COEP at Coeptis Therapeutics at Buy With $10 Price Target MT
JonesTrading Initiates Coeptis Therapeutics at Buy With $4 Price Target MT
EF Hutton Initiates Coeptis Therapeutics With Buy Rating, Price Target is $6 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.285 USD
Average target price
3 USD
Spread / Average Target
+952.63%
High Price Target
3 USD
Spread / Highest target
+952.63%
Low Price Target
3 USD
Spread / Lowest Target
+952.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Coeptis Therapeutics Holdings, Inc.

Ladenburg Thalmann
EF Hutton
JonesTrading Institutional Services

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. COEP Stock
  4. Consensus Coeptis Therapeutics Holdings, Inc.